Table 2.

The expression of MTA1 in luminal-b breast cancer progression.

Item		Expression of MTA1		P Value
		High Expression	Low expression
Age	<46	19(20.2%)	35(37.2%)	0.015
	>45	75(79.8%)	59(62.8%)
Clinical Stage	I~II	52(55.3%)	66(70.2%)	0.023
	III~IV	42(44.7%)	26(29.8%)
Survival	Mean value	818.2	1088.6	0.029
	Death Events	21.3%	13.8%